Incidence of Early Infection After Bipolar Hemiarthroplasty and Its Associated Factors in Fracture Neck of Femur

May 23, 2024 updated by: Ahmed Sallam Abo El-azaiem Mohamed, Assiut University
Periprosthetic joint infections (PJI) following hemiarthroplasty for hip fractures are a catastrophic complication that results in severe worsening of patients' daily function and quality of life. The incidence of prosthetic joint infection (PJI) in hemiarthroplasty after femoral neck fracture varies from 2% to 17%. Identifying risk factors associated with early infection following HA for hip fractures may provide an opportunity to treat and prevent this potential complication with preoperative planning in many patients. So investigators will study the rate of early infection and its associated factor after bipolar hemiarthroplasty.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Femoral neck fractures (FNF) have a significant incidence and a rising trend worldwide. FNF is associated with a high mortality and disability rate, decreasing the independence and quality of life for affected patients. Acute displaced intracapsular femoral neck fractures account for about half of all hip fractures, with the majority of these fractures in older patients being treated surgically with hip hemiarthroplasty(HA), total hip arthroplasty, or internal fixation. Hemiarthroplasty is also used to treat femoral neck nonunion, failed screw fixation, and pathological femoral neck fracture. The treatment aims are to reduce pain, allow early mobilization, and restore the patient's pre-injury level of function while limiting perioperative surgical and medical complications. Patients with FNF frequently undergo hemiarthroplasty to restore joint biomechanics. Two types of implants are used in hemiarthroplasty: monopolar and bipolar . The bipolar implants have a polyethylene bearing between the stem and head of the endoprosthesis, which allows the components to rotate. There are debatable findings and a lack of consensus on the optimal component for hemiarthroplasty. Periprosthetic joint infections (PJI) following hemiarthroplasty for hip fractures are a catastrophic complication that results in severe worsening of patients' daily function and quality of life. The incidence of prosthetic joint infection (PJI) in hemiarthroplasty after femoral neck fracture varies from 2% to 17%. Identifying risk factors associated with early infection following HA for hip fractures may provide an opportunity to treat and prevent this potential complication with preoperative planning in many patients. So investigators will study the rate of early infection and its associated factor after bipolar hemiarthroplasty.

Study Type

Observational

Enrollment (Estimated)

74

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

  • Study Setting: Department of Orthopedic and Trauma Surgery, Assiut University.
  • Study subjects:

    a. Inclusion criteria:

  • Patients with femoral neck fractures and treated by bipolar hemiarthroplasty.
  • Patients or their legal representative able to give informed consent. b. Exclusion criteria:
  • Patients that received HA secondary to a failed internal fixation of a femoral neck fracture.
  • Patients with a pathological fracture due to malignancy.

Description

Inclusion Criteria:

  • Patients with femoral neck fractures and treated by bipolar hemiarthroplasty.
  • Patients or their legal representative able to give informed consent.

Exclusion Criteria:

  • Patients that received HA secondary to a failed internal fixation of a femoral neck fracture.
  • Patients with a pathological fracture due to malignancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
group 1 diseased group(infected)
the presence of persistent discharge after 7 days diagnostic for early infection follow up period first 4 week postoperative bipolar hemiarthroplasty in fracture neck of femur study the risk factors in this group
bipolar hemiarthroplasty for neck femur fracture
group 2 : control group (normal )
no infection after hemiarthroplasty follow up period first 4 week postoperative bipolar hemiarthroplasty in fracture neck of femur
bipolar hemiarthroplasty for neck femur fracture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
incidence of early infection after bipolar hemiarthroplasty
Time Frame: 4 weeks postoperative

investigators will take all cases with bipolar hemiarthroplasty after femoral neck fracture then follow up them for 4 weeks. An infection was categorized as early, if it occurred within 4 weeks after surgery After that investigators will classify them to infected (disease group) and non infected (control group) and studying risk factor predisposing to early infection after HA.

For diagnosis of infection : the presence of persistent discharge after 7 days

4 weeks postoperative
risk factor predisposing to early infection after HA.1-preoperative parameters :Patient age
Time Frame: preoperative evaluation 1 week
Age in years
preoperative evaluation 1 week
risk factor predisposing to early infection after HA.1-preoperative parameters :sex
Time Frame: preoperative evaluation 1 week
male or female
preoperative evaluation 1 week
risk factor predisposing to early infection after HA.1-preoperative parameters :Chronic diseases as Diabetes, rheumatoid arthritis and other inflammatory or autoimmune arthritis.
Time Frame: preoperative evaluation 1 week
present or not
preoperative evaluation 1 week
risk factor predisposing to early infection after HA.1-preoperative parameters : • Active skin disease (at site of surgical incision)
Time Frame: preoperative evaluation 1 week
present or not
preoperative evaluation 1 week
risk factor predisposing to early infection after HA.1-preoperative parameters : • Smoking and alcohol consumption
Time Frame: preoperative evaluation 1 week
yes or no
preoperative evaluation 1 week
risk factor predisposing to early infection after HA.1-preoperative parameters : • Distant septic focus after arthroplasty as (pneumonia ,UTI ,abdominal ,oral and cutaneous infection).
Time Frame: preoperative evaluation 1 week
present or no
preoperative evaluation 1 week
risk factor predisposing to early infection after HA.2-intraoperative parameters : • Surgery time .
Time Frame: at time of operation
in hours
at time of operation
risk factor predisposing to early infection after HA.2-intraoperative parameters :• Appropriate antibiotics prophalyxis and Need to blood transfusion.
Time Frame: at time of operation
yes or no
at time of operation
risk factor predisposing to early infection after HA.3-postoperative parameters :• Persistent drainage after 7 days.
Time Frame: 1 week postoperative
time in days
1 week postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2024

Primary Completion (Estimated)

June 1, 2025

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

May 15, 2024

First Submitted That Met QC Criteria

May 23, 2024

First Posted (Actual)

May 24, 2024

Study Record Updates

Last Update Posted (Actual)

May 24, 2024

Last Update Submitted That Met QC Criteria

May 23, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prosthetic-joint Infection

Clinical Trials on bipolar hemiarthroplasty

3
Subscribe